Botulinum toxin A and chronic low back pain a randomized, double-blind study

Neurology

Volumn 56, Issue 10, 2001, Pages 1290-1293

  Foster, Leslie ^a,b   Clapp, Larry ^c   Erickson, Marleigh ^a,b   Jabbari, Bahman ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; HUMAN TISSUE; LOW BACK PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RATING SCALE;

EID: 0035933051     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.10.1290     Document Type: Article

References (32)

1. Wipf JE, Deyo RA. Low back pain. Med Clin North Am 1995; 79:231-246.
2. Frymoyer JW. Predicting disability from low back pain. Clin Orthop Rel Res 1992;279:101-109.
3. Nachemson A. Newest knowledge of low back pain. Clin Orthop Rel Res 1992;279:8-20.
4. Bigos S, Bowyer O, Braen G. Acute low back problems in adults. Clinical Practice Guideline No. 14, AHCPR Publication No 95-0642 ed. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services, 1994:160.
5. Greene P, Kang U, Fahn S, et al. Double blind, placebo controlled trial of botulinum toxin injection for the treatment of spasmodic torticollis. Neurology 1990;40:1213-1218.
6. Karp BI Cole RA, Cohen LG, et al. Long-term botulinum toxin treatment of focal hand dystonia. Neurology 1994;44:70-76.
7. Grazko MA, Polo KB, Jabbari B. Botulinum toxin A for spasticity muscle spasms, and rigidity. Neurology 1995;45:712-717.
8. Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994;59:65-69.
9. Cavanaugh JM, Weinstein JN. Low back pain: epidemiology, anatomy and physiology. In: Wall PD, Melzack R eds. Textbook of pain. 3rd ed. Edinburgh: Churchill Livingstone, 1994: 441-455.
10. Wheeler A, Goelkusian PA, Gretz SS. Randomized, doubleblind, prospective pilot study of botulinum toxin injection for refractory unilateral, cervicothoracic, paraspinal, myofacial pain syndrome. Spine 1998;23:1662-1667.
11. Freund BJ, Schwartz M. Treatment of whiplash associated neck pain with Botox: report of 8 cases. J Rheumatol 1999;26: 756-8.
12. Button JJ. Botulinum toxin in treatment of craniocervical muscle spasms short and long term, local and systemic effects. Surv Ophthalmol 1996;41:51-65.
13. Frost H, Klaber Moffett JA, Moser JS, et al. Randomised controlled trial for evaluation of fitness programme for patients with chronic low back pain. BMJ 1995;310:151-154.
14. Price DD, Bush FM, Long S, et al. A comparison of pain measurement characteristics of mechanical visual analogue and simple numerical rating scales. Pain 1994;56:217-226.
15. Fairbanks JCT, Couper J, Davies JB, et al. The Oswestry Low Back Pain Disability Questionnaire. Physiotherapy 1980;66: 271-273.
16. Nouwen A, Bush C. The relationship between paraspinal EMG and chronic low back pain. Pain 1984;20:109-123.
17. DeVries HA. EMG fatigue curves in postural muscles. A possible etiology for idiopathic low back pain. Am J Phys Med 1968;47:175-181.
18. Ravitz E, Moore ME, Glaros A. Paralumbar muscle activity in chronic low back pain. Arch Phys Med Rehabil 1981;62:172-176.
19. Sherman RA. Relationships between strength of low back muscle contraction and reported intensity of chronic low back pain. Am J Phys Med 1985;64:190-200.
20. Kuslich SD, Ulstrom CL, Michael CJ. The tissue origin of low back pain and sciatica: a report of pain response to tissue stimulation during operations on the lumbar spine using local anesthesia. Orthop Clin North Am 1991;22:181-187.
21. Horgorani K. Diazepam in backache: a double blind controlled trial. Ann Phys Med 1965;8:303-306.
22. Borenstein DG, Lacks S, Wiesel SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther 1990;12:125-131.
23. Fillipi GM, Errico P, Santarelli R, et al. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolarynol 1993;113: 400-404.
24. Roberts WJ. A hypothesis on the physiological basis for causalgia and related pains. Pain 1986;24:297-311.
25. Rand MJ, Whaler BC. Impairment of sympathetic transmission by botulinum toxin. Nature 1965;206:588-591.
26. Gillette RG, Kramis RC, Roberts WJ. Sympathetic activation of cat spinal neurons responsive to noxious stimulation of deep tissues in the low back. Pain 1994;31-42:
27. Hagenah R, Benecke R, Wiegand H. Effects of type A botulinum toxin on the cholinergic transmission at spinal Renshaw cells and on the inhibitory action at Ia inhibitory interneurons. Naunyn Schmiedebergs Arch Pharmacol 1997;299:267-72.
28. Wiegand H, Erdmann G, Welhoner HH. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976; 292:161-165.
29. Guyer B. Mechanism of botulinum toxin in the relief of chronic pain. Curr Rev Pain 1999;3:427-431
30. Hallett M. How does botulinum toxin work. Ann Neurol 2000; 48:7-8.
31. Comella CL, Shannon K, Jaglin J. Extensor truncal dystonia. Successful treatment with botulinum toxin injections. Mov Disord 1998;13:552-555.
32. Davis D, Jabbari B. Significant improvement of stiff-person syndrome after paraspinal injection of botulinum toxin A. Mov Disord 1993;8:371-373.